| Articles Reviewed |
| 1: | Norman G Nagl et al. Distinct mammalian SWI/SNF chromatin remodeling complexes with opposing roles in cell-cycle control. 2007 |
| 2: | Lauren A Zenewicz et al. Interleukin-22 but not interleukin-17 provides protection to hepatocytes during acute liver inflammation. 2007 |
| 3: | Zhendong Ma et al. Mutations of HNF-1beta inhibit epithelial morphogenesis through dysregulation of SOCS-3. 2007 |
| 4: | Almira S Punjabi et al. Persistent activation of STAT3 by latent Kaposi's sarcoma-associated herpesvirus infection of endothelial cells. 2007 |
| 5: | Marjan Berishaj et al. Stat3 is tyrosine-phosphorylated through the interleukin-6/glycoprotein 130/Janus kinase pathway in breast cancer. 2007 |
| 6: | Ana Quaglino et al. Mouse mammary tumors display Stat3 activation dependent on leukemia inhibitory factor signaling. 2007 |
| 7: | Janeen Azare et al. Constitutively activated Stat3 induces tumorigenesis and enhances cell motility of prostate epithelial cells through integrin beta 6. 2007 |
| 8: | Evdokia Dimitriadis et al. Immunolocalisation of phosphorylated STAT3, interleukin 11 and leukaemia inhibitory factor in endometrium of women with unexplained infertility during the implantation window. 2007 |
| 9: | T Hirai et al. PDGF receptor tyrosine kinase inhibitor suppresses mesangial cell proliferation involving STAT3 activation. 2006 |
| 10: | Cora Weigert et al. Direct cross-talk of interleukin-6 and insulin signal transduction via insulin receptor substrate-1 in skeletal muscle cells. 2006 |
| 11: | F E Utama et al. Human prolactin receptors are insensitive to mouse prolactin: implications for xenotransplant modeling of human breast cancer in mice. 2006 |
| 12: | Evdokia Dimitriadis et al. Interleukin 11 signaling components signal transducer and activator of transcription 3 (STAT3) and suppressor of cytokine signaling 3 (SOCS3) regulate human endometrial stromal cell differentiation. 2006 |
| 13: | Athanasios Stratis et al. Pathogenic role for skin macrophages in a mouse model of keratinocyte-induced psoriasis-like skin inflammation. 2006 |
| 14: | Mariko Tomita et al. Inhibition of constitutively active Jak-Stat pathway suppresses cell growth of human T-cell leukemia virus type 1-infected T-cell lines and primary adult T-cell leukemia cells. 2006 |
| 15: | Sylvia M Major et al. AbMiner: a bioinformatic resource on available monoclonal antibodies and corresponding gene identifiers for genomic, proteomic, and immunologic studies. 2006 |
| 16: | Frank J Delfino et al. A growth-suppressive function for the c-fes protein-tyrosine kinase in colorectal cancer. 2006 |
| 17: | Anja Persson et al. A human protein atlas based on antibody proteomics. 2006 |
| 18: | Weihua Wan et al. Anaplastic lymphoma kinase activity is essential for the proliferation and survival of anaplastic large-cell lymphoma cells. 2006 |
| 19: | Karyn L Butler et al. STAT-3 activation is necessary for ischemic preconditioning in hypertrophied myocardium. 2006 |
| 20: | David A Taylor-Fishwick et al. PDX-1 can repress stimulus-induced activation of the INGAP promoter. 2006 |
| 21: | Seiji Ueno et al. Plasma membrane-associated sialidase is up-regulated in renal cell carcinoma and promotes interleukin-6-induced apoptosis suppression and cell motility. 2006 |
| 22: | Katri Saavalainen et al. The human hyaluronan synthase 2 gene is a primary retinoic acid and epidermal growth factor responding gene. 2005 |
| 23: | Marylynn Snyder et al. The DNA replication factor MCM5 is essential for Stat1-mediated transcriptional activation. 2005 |
| 24: | Veronica Novotny-Diermayr et al. Modulation of the interleukin-6 receptor subunit glycoprotein 130 complex and its signaling by LMO4 interaction. 2005 |
| 25: | Akihiko Numata et al. Signal transducers and activators of transcription 3 augments the transcriptional activity of CCAAT/enhancer-binding protein alpha in granulocyte colony-stimulating factor signaling pathway. 2005 |
| 26: | Ye Zhou et al. Formylpeptide receptor FPR and the rapid growth of malignant human gliomas. 2005 |
| 27: | Xiao Liang Zhang et al. Interleukin-6 regulation of transforming growth factor (TGF)-beta receptor compartmentalization and turnover enhances TGF-beta1 signaling. 2005 |
| 28: | Masato Moriguchi et al. CXCL12 signaling is independent of Jak2 and Jak3. 2005 |
| 29: | Dayanand D Deo et al. Activation of platelet-activating factor receptor-coupled G alpha q leads to stimulation of Src and focal adhesion kinase via two separate pathways in human umbilical vein endothelial cells. 2004 |
| 30: | Stephan Kiessling et al. Functional expression of the interleukin-11 receptor alpha-chain and evidence of antiapoptotic effects in human colonic epithelial cells. 2004 |
| 31: | Chong-Shan Shi et al. Pyk2 amplifies epidermal growth factor and c-Src-induced Stat3 activation. 2004 |
| 32: | Nicholas Torpey et al. Interferon alpha but not interleukin 12 activates STAT4 signaling in human vascular endothelial cells. 2004 |
| 33: | Guoqing Yang et al. Modulation of direct leptin signaling by soluble leptin receptor. 2004 |
| 34: | Patricia M-J Lievens et al. The kinase activity of fibroblast growth factor receptor 3 with activation loop mutations affects receptor trafficking and signaling. 2004 |
| 35: | Vidya Mamidipudi et al. RACK1 regulates G1/S progression by suppressing Src kinase activity. 2004 |
| 36: | Wei Tong et al. Lnk inhibits Tpo-mpl signaling and Tpo-mediated megakaryocytopoiesis. 2004 |
| 37: | Achara Srisodsai et al. Interleukin-10 induces uteroglobin-related protein (UGRP) 1 gene expression in lung epithelial cells through homeodomain transcription factor T/EBP/NKX2.1. 2004 |
| 38: | Hayley A Whittington et al. Interleukin-22: a potential immunomodulatory molecule in the lung. 2004 |
| 39: | Laure Dumoutier et al. Role of the interleukin (IL)-28 receptor tyrosine residues for antiviral and antiproliferative activity of IL-29/interferon-lambda 1: similarities with type I interferon signaling. 2004 |
| 40: | Sylvain Pradervand et al. Small proline-rich protein 1A is a gp130 pathway- and stress-inducible cardioprotective protein. 2004 |
| 41: | G Jayarama Bhat et al. alpha-thrombin rapidly induces tyrosine phosphorylation of a novel, 74-78-kDa stress response protein(s) in lung fibroblast cells. 2004 |
| 42: | Panos G Ziros et al. Growth hormone attenuates the transcriptional activity of Runx2 by facilitating its physical association with Stat3beta. 2004 |
| 43: | Annie Lacerte et al. Activin inhibits pituitary prolactin expression and cell growth through Smads, Pit-1 and menin. 2004 |
| 44: | Wengang Wang et al. PC cell-derived growth factor (granulin precursor) expression and action in human multiple myeloma. 2003 |
| 45: | Rico K H Lo et al. Constitutively active Galpha16 stimulates STAT3 via a c-Src/JAK- and ERK-dependent mechanism. 2003 |
| 46: | Suhendan Ekmekcioglu et al. Negative association of melanoma differentiation-associated gene (mda-7) and inducible nitric oxide synthase (iNOS) in human melanoma: MDA-7 regulates iNOS expression in melanoma cells. 2003 |
| 47: | Hai Ou Duan et al. Functional analysis of interleukin 6 response elements (IL-6REs) on the human gamma-fibrinogen promoter: binding of hepatic Stat3 correlates negatively with transactivation potential of type II IL-6REs. 2003 |
| 48: | Peter Stärkel et al. Expression and DNA-binding activity of signal transducer and activator of transcription 3 in alcoholic cirrhosis compared to normal liver and primary biliary cirrhosis in humans. 2003 |
| 49: | K C Leung et al. Estrogen inhibits GH signaling by suppressing GH-induced JAK2 phosphorylation, an effect mediated by SOCS-2. 2003 |
| 50: | Mayu Minoguchi et al. STAP-2/BKS, an adaptor/docking protein, modulates STAT3 activation in acute-phase response through its YXXQ motif. 2003 |
| 51: | Sanjin Zvonic et al. The regulation and activation of ciliary neurotrophic factor signaling proteins in adipocytes. 2003 |
| 52: | Dayanand D Deo et al. Phosphorylation of STAT-3 in response to basic fibroblast growth factor occurs through a mechanism involving platelet-activating factor, JAK-2, and Src in human umbilical vein endothelial cells. Evidence for a dual kinase mechanism. 2002 |
| 53: | Thirupandiyur S Udayakumar et al. Fibroblast growth factor-1 induced promatrilysin expression through the activation of extracellular-regulated kinases and STAT3. 2002 |
| 54: | Jayasree S Nair et al. Requirement of Ca2+ and CaMKII for Stat1 Ser-727 phosphorylation in response to IFN-gamma. 2002 |
| 55: | Keyvan Mahboubi et al. Activation of signal transducer and activator of transcription 1 (STAT1) is not sufficient for the induction of STAT1-dependent genes in endothelial cells. Comparison of interferon-gamma and oncostatin M. 2002 |
| 56: | Diane Lejeune et al. Interleukin-22 (IL-22) activates the JAK/STAT, ERK, JNK, and p38 MAP kinase pathways in a rat hepatoma cell line. Pathways that are shared with and distinct from IL-10. 2002 |
| 57: | Xin Hu et al. Leptin--a growth factor in normal and malignant breast cells and for normal mammary gland development. 2002 |
| 58: | Alfredo MartĂnez et al. The effects of adrenomedullin overexpression in breast tumor cells. 2002 |
| 59: | Mai Wang et al. Interleukin 24 (MDA-7/MOB-5) signals through two heterodimeric receptors, IL-22R1/IL-20R2 and IL-20R1/IL-20R2. 2002 |
| 60: | Ladislav Burysek et al. The serine protease plasmin triggers expression of MCP-1 and CD40 in human primary monocytes via activation of p38 MAPK and janus kinase (JAK)/STAT signaling pathways. 2002 |
| 61: | D Lejeune et al. Interleukin 9 induces expression of three cytokine signal inhibitors: cytokine-inducible SH2-containing protein, suppressor of cytokine signalling (SOCS)-2 and SOCS-3, but only SOCS-3 overexpression suppresses interleukin 9 signalling. 2001 |
| 62: | M Jost et al. Epidermal growth factor receptor-dependent control of keratinocyte survival and Bcl-xL expression through a MEK-dependent pathway. 2001 |
| 63: | E Avota et al. Disruption of Akt kinase activation is important for immunosuppression induced by measles virus. 2001 |
| 64: | H Asao et al. Cutting edge: the common gamma-chain is an indispensable subunit of the IL-21 receptor complex. 2001 |
| 65: | A H Wong et al. Enhanced antiviral and antiproliferative properties of a STAT1 mutant unable to interact with the protein kinase PKR. 2001 |
| 66: | T Hideshima et al. The proteasome inhibitor PS-341 inhibits growth, induces apoptosis, and overcomes drug resistance in human multiple myeloma cells. 2001 |
| 67: | D M Stewart et al. Interferon-tau activates multiple signal transducer and activator of transcription proteins and has complex effects on interferon-responsive gene transcription in ovine endometrial epithelial cells. 2001 |
| 68: | F Cavallo et al. Interleukin 12-activated lymphocytes influence tumor genetic programs. 2001 |
| 69: | F Blanchard et al. Oncostatin M regulates the synthesis and turnover of gp130, leukemia inhibitory factor receptor alpha, and oncostatin M receptor beta by distinct mechanisms. 2001 |
| 70: | J I Leu et al. Interleukin-6-induced STAT3 and AP-1 amplify hepatocyte nuclear factor 1-mediated transactivation of hepatic genes, an adaptive response to liver injury. 2001 |